Alcohol and Sugar Impact on Liver Metabolism
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to understand how alcohol (ETOH) and sugar affect liver fat production in healthy adults. Participants will consume a small amount of vodka, with or without added sugar, while researchers measure changes in liver fat synthesis. Men and women who are generally healthy, consume alcohol lightly to moderately, and have a body mass index (BMI) between 18.5 and 29.9 are suitable candidates. As an unphased trial, this study allows participants to contribute to valuable research on liver health and the effects of alcohol and sugar.
Will I have to stop taking my current medications?
Yes, you will need to stop taking any regular medications, except for oral contraceptives, to participate in this trial.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that alcohol can significantly affect the liver, especially with frequent or heavy drinking. Long-term alcohol use can lead to liver problems, such as fatty liver and other metabolic issues. However, this study uses a controlled amount of alcohol, not long-term use, which reduces the risks linked to heavy drinking.
Regarding sucrose, a type of sugar, studies have found that replacing some energy intake with sucrose usually doesn't increase heart or metabolism risks in healthy adults. However, regularly consuming sugary beverages can affect liver metabolism and may increase the risk of liver issues.
This study carefully controls the amounts of both alcohol and sucrose that participants consume, helping to manage and minimize potential risks associated with these substances in the short term.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores how alcohol and sugar impact liver metabolism in unique ways. Unlike typical studies focusing solely on alcohol or sugar separately, this trial investigates their combined effect on liver fat production, known as de novo lipogenesis. By using deuterated water to trace metabolic changes, researchers can gain detailed insights into how these substances influence liver function over time. This approach may reveal new information about metabolic processes, potentially informing future dietary guidelines or interventions for liver health.
What evidence suggests that this trial's treatments could be effective for liver metabolism?
This trial will compare the effects of alcohol and sucrose on liver metabolism. Research has shown that alcohol, such as ethanol, affects liver fat processing by increasing de novo lipogenesis (DNL), the body's process of making new fat. Participants in one arm of this trial will receive alcohol to study its impact on DNL. Consuming large amounts of sucrose, a type of sugar, has also been linked to increased DNL, especially compared to other sugars like glucose. Participants in another arm will receive sucrose to evaluate its effects. Sucrose and fructose, which is very similar, more effectively prompt the liver to produce fat, impacting metabolic health. Additionally, one arm will study the combined effects of alcohol and sucrose on liver metabolism.678910
Are You a Good Fit for This Trial?
This trial is for healthy men and women aged 21-45, with a BMI of 18.5-29.9, who drink alcohol lightly to moderately. They must understand English but can't participate if they're pregnant, breastfeeding, have a high BMI (>29.9), take regular medications (except oral contraceptives), or exercise heavily.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants consume deuterated water and alcohol or sucrose beverages, with blood samples collected to measure hepatic de novo lipogenesis
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- ETOH
- Sucrose
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Texas Southwestern Medical Center
Lead Sponsor